Advertisement
Advertisement
PACB
Pacific Biosciences of California, Inc.
1.81
USDSponsored
+0.10
+5.83%
Feb 06, 15:58 UTC -5
Closed
After-Market
1.82
+0.01
+0.28%
PACB Earnings Reports
Positive Surprise Ratio
PACB beat 19 of 39 last estimates.
49%
Next Report
Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$43.10M
/-$0.15
Implied change from Q3 25 (Revenue/ EPS)
+12.13%
/+15.38%
Implied change from Q4 24 (Revenue/ EPS)
+9.89%
/-69.39%
Pacific Biosciences of California, Inc. earnings per share and revenue
On Nov 05, 2025, PACB reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.15 USD, resulting in a 16.13% surprise. Revenue reached 38.44 million, compared to an expected 41.01 million, with a -6.27% difference. The market reacted with a -7.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 43.10 million USD, implying an increase of 15.38% EPS, and increase of 12.13% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Pacific Biosciences of California, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Pacific Biosciences of California, Inc. reported EPS of -$0.13, beating estimates by 16.13%, and revenue of $38.44M, -6.27% below expectations.
How did the market react to Pacific Biosciences of California, Inc.'s Q3 2025 earnings?
The stock price moved down -7.05%, changed from $1.92 before the earnings release to $1.78 the day after.
When is Pacific Biosciences of California, Inc. expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Pacific Biosciences of California, Inc.'s next earnings report?
Based on 10
analysts, Pacific Biosciences of California, Inc. is expected to report EPS of -$0.15 and revenue of $43.10M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement